This Could Be Pfizer's Next COVID Blockbuster -- and It Isn't a Vaccine

Submitted by admin on August 3, 2021 - 10:57am

Source:

Motley Fool

News Tags:

Headline:

snippet:

Pfizer recently announced promising results for its oral protease inhibitor in post-exposure prophylaxis for COVID-19.
The company estimates a potential addressable market for the therapy of up to hundreds of millions of patients if successful.
Pfizer advanced the experimental drug into phase 2/3 testing in July and thinks it could file for EUA in Q4 if all goes well.

Search form